DRUGS
  (See also ALCOHOL AND DRUG ABUSE; CIVIL PROCEDURE; CRIMINAL PROCEDURE; HEALTH AND SAFETY, PUBLIC) |
|
Assistance with medications, as activity of daily living in assisted living facilities:
HB 1671,
*
SHB 1671, CH 201 (2017), SB 5510 |
|
Benzodiazepines, prescribing, prescription monitoring program history review:
HB 2325, SB 6028 |
|
Birth control, contraceptive drugs, health plan coverage for twelve-month supply:
HB 1234,
*
SHB 1234, CH 293 (2017), SB 5554, SSB 5554 |
|
Cannabidiol and cannabinoid products, retailer health safety sign display:
HB 2333 |
|
Cannabidiol products, as additive in marijuana products:
HB 2334, SHB 2334,
*
E2SHB 2334, CH 132 (2018) |
|
Cannabis, health and beauty aids, permit for, and regulatory requirements:
HB 2033, SB 5698 |
|
Cannabis, medical use, provisions:
HB 1060, SHB 1060, HB 1094, HB 1098, HB 1212, SHB 1212,
*
HB 1250, CH 131 (2017), HB 1416, HB 2021, SHB 2021, HB 2098, ESHB 2098,
*
ESSB 5131, CH 317 (2017), SB 5290, SB 5606, SB 5928,
*
ESSB 5928, CH 68 (2018), SB 5933 |
|
Cannabis, medical use, repealing all statutes legalizing:
HB 2096 |
|
Clinical trials, demographic diversity program for:
HB 2304, SB 6506 |
|
Collaboration drug therapy agreements, vaccines and contraceptives, at pharmacies:
EHB 2570 |
|
Contraceptive drugs, health plan reimbursement for twelve-month-supply refills:
HB 1234,
*
SHB 1234, CH 293 (2017), SB 5554, SSB 5554 |
|
Controlled substances, drug-free zone perimeters, widening, when:
HB 2794 |
|
Controlled substances, electronic communication of prescription information:
HB 2689 |
|
Controlled substances, endangerment of dependent with:
HB 2884, SB 5988 |
|
Controlled substances, possession without prescription, misdemeanor:
HB 1087 |
|
Controlled substances, prescribing, prescription monitoring program history review:
HB 2325, SB 6028 |
|
Controlled substances, prohibited acts, special allegations and enhancements:
HB 2835 |
|
Controlled substances, schedule II or III oral, graded dosage packs for:
HB 2586 |
|
Controlled substances, trafficking, orders for communication interception:
HB 1108 |
|
Controlled substances, uniform act, asset forfeiture hearings, burden of proof:
SB 5044 |
|
Controlled substances, uniform act, asset forfeiture, seizing-agency records:
SB 5255, SSB 5255 |
|
Controlled substances, uniform act, excluding industrial hemp from scope of:
*
HB 2064, CH 153 (2017) |
|
Controlled substances, uniform act, property forfeiture, using proceeds for school funding:
HB 2136 |
|
Controlled substances, uniform act, property seizure and forfeiture, procedures and reporting:
HB 2718, SHB 2718, E2SHB 2718 |
|
Felony drug offenses, forfeiture of private property, guilty finding for:
HB 1016 |
|
Heroin, use in presence of person under 18, special allegation:
HB 2835 |
|
Investigational drugs and biological products, terminally ill patient access, when:
SB 5035,
*
SSB 5035, CH 212 (2017) |
|
Investigational drugs, biological products, and devices, access by certain patients:
HB 1242 |
|
Marijuana odors, task force on, convening:
HB 2845 |
|
Marijuana retailers or products, billboards advertising, prohibiting:
HB 2727 |
|
Marijuana, all statutes legalizing, repealing:
HB 2096 |
|
Marijuana, businesses and entities, siting near tribal reservation, provisions:
HB 1937 |
|
Marijuana, businesses, accounting services for, authorizing:
ESHB 2098,
*
ESSB 5928, CH 68 (2018) |
|
Marijuana, businesses, armored car services for, authorizing:
ESHB 2098,
*
ESSB 5928, CH 68 (2018) |
|
Marijuana, businesses, business and nonprofit entity interest holders' residency:
HB 1127, HB 1151, SHB 1151, SB 5102, SSB 5102, SB 5284 |
|
Marijuana, businesses, by playground, child care center, or preschool, prohibitions:
HB 2238, HB 2483, SB 6348 |
|
Marijuana, businesses, by school bus stop, prohibition:
HB 2483 |
|
Marijuana, businesses, contracts between processors, producers, and retailers:
ESHB 2472 |
|
Marijuana, businesses, financial institution services for, authorizing:
HB 2098, ESHB 2098, SB 5928,
*
ESSB 5928, CH 68 (2018) |
|
Marijuana, businesses, general licensing process:
EHB 1857, SB 5131,
*
ESSB 5131, CH 317 (2017) |
|
Marijuana, businesses, hidden ownership or misrepresentation of fact:
HB 2770 |
|
Marijuana, businesses, license applicants, persons or entities considered to be:
HB 2770 |
|
Marijuana, businesses, license issuance, regulatory compliance determinations for:
HB 2630 |
|
Marijuana, businesses, license issuance, tribal consent for, when:
*
ESSB 5131, CH 317 (2017) |
|
Marijuana, businesses, licensing agreements and consulting contracts with entities:
HB 1152, SHB 1152, SB 5101,
*
ESSB 5131, CH 317 (2017) |
|
Marijuana, businesses, paying with or accepting virtual currency, prohibiting:
SB 5264 |
|
Marijuana, businesses, production and processing standards for licensees:
HB 1461,
*
ESSB 5131, CH 317 (2017), SB 5323 |
|
Marijuana, businesses, retailer contracts with processors:
HB 2472, SB 6171 |
|
Marijuana, businesses, revenues from, federal activities impeding, prohibitions:
HB 2124 |
|
Marijuana, businesses, robbery of, as special allegation for robbery:
HB 2850, SB 5284 |
|
Marijuana, businesses, signage and advertising:
*
ESSB 5131, CH 317 (2017), SB 5284, SSB 5284 |
|
Marijuana, businesses, siting of, prohibitions:
HB 2238, HB 2483, SB 6348 |
|
Marijuana, businesses, siting or operation of retail, processes for prohibiting:
HB 2215, HB 2336, SHB 2336, HB 2484, SB 6291 |
|
Marijuana, businesses, siting or operation of, processes for prohibiting:
HB 2336, SHB 2336, HB 2484, SB 6291 |
|
Marijuana, businesses, targeting youth, prohibiting:
*
ESSB 5131, CH 317 (2017) |
|
Marijuana, businesses, targeting children, youth, and young adults, prohibiting:
SB 5284, SSB 5284 |
|
Marijuana, businesses, various licensing provisions:
EHB 1857, SB 5131,
*
ESSB 5131, CH 317 (2017), SB 5284 |
|
Marijuana, cannabis health and beauty aids permit and regulatory requirements:
HB 2033, SB 5698 |
|
Marijuana, enforcement, powers of liquor enforcement officers:
SB 5132, SSB 5132 |
|
Marijuana, excise tax provisions:
HB 1667, SHB 1712, HB 2021, HB 2060, HB 2076, HB 2124, SB 6552 |
|
Marijuana, excise tax, Alaskan Way viaduct project cost overruns payment via:
HB 2193 |
|
Marijuana, excise taxation, excluding from agricultural products exemption:
HB 2358 |
|
Marijuana, facilities, odors or dust from, clean air act exemption, when:
HB 2882 |
|
Marijuana, federal efforts concerning, state resources use to assist, prohibiting:
HB 1895 |
|
Marijuana, hydrocarbon gas-based marijuana-processing solvent, taxing, when:
HB 1667 |
|
Marijuana, illicit production of, drug enforcement task force for controlling, creating:
HB 2972 |
|
Marijuana, indoor cultivation of, local government ordinances requiring:
HB 2960 |
|
Marijuana, inhaling in presence of person under 18, civil infraction:
HB 1625 |
|
Marijuana, legalizing recreational user plant possession, regulation of, studying:
*
ESSB 5131, CH 317 (2017) |
|
Marijuana, licenses, additional application and renewal fee:
EHB 1858, 2SHB 2227,
*
SB 5130, CH 316 (2017) |
|
Marijuana, licenses, research license provisions:
EHB 1857, SB 5131,
*
ESSB 5131, CH 317 (2017), SB 5451 |
|
Marijuana, medical use, accounting services for businesses:
ESHB 2098,
*
ESSB 5928, CH 68 (2018) |
|
Marijuana, medical use, administration to students:
HB 1060, SHB 1060, SB 5290 |
|
Marijuana, medical use, armored car services for businesses:
ESHB 2098,
*
ESSB 5928, CH 68 (2018) |
|
Marijuana, medical use, authorization database, changing funding source for:
HB 2566 |
|
Marijuana, medical use, compassionate care renewals for patients:
HB 2554, SHB 2554 |
|
Marijuana, medical use, cooperatives, state preemption of regulation of:
HB 2471 |
|
Marijuana, medical use, financial services for businesses, patients, providers:
HB 2098, ESHB 2098, SB 5928,
*
ESSB 5928, CH 68 (2018) |
|
Marijuana, medical use, hiring and accommodation of patient by employer:
HB 1094 |
|
Marijuana, medical use, personal product testing for qualified patients:
HB 1212, SHB 1212 |
|
Marijuana, medical use, provisions:
HB 1094, HB 1098,
*
HB 1250, CH 131 (2017), HB 1416, HB 2021, SHB 2021,
*
ESSB 5131, CH 317 (2017), SB 5606, SB 5933 |
|
Marijuana, medical use, repealing all statutes legalizing:
HB 2096 |
|
Marijuana, medical use, retailer delivery to patient, endorsement for:
HB 2574 |
|
Marijuana, medical use, retailer home delivery, creating system for, studying:
SHB 2574 |
|
Marijuana, medical use, tribal retailer deliveries to patients:
HB 2574 |
|
Marijuana, nonmedical, home cultivation, removing prohibition, when:
HB 2559, SB 6482 |
|
Marijuana, possession of plants and useable marijuana at home:
HB 1092, HB 1212, SHB 1212 |
|
Marijuana, possession, delivery, and/or transfer offenses, penalty modifications:
HB 1065, SHB 1065, HB 1212 |
|
Marijuana, possession, misdemeanor convictions, vacation of:
HB 1260 |
|
Marijuana, possession, misdemeanor, conveyance forfeiture exception for:
HB 1087 |
|
Marijuana, possession, misdemeanor, repealing:
SB 5904 |
|
Marijuana, possession, standards for legal:
SHB 1212,
*
ESSB 5131, CH 317 (2017) |
|
Marijuana, possession, standards for legal, misdemeanor, and felony:
HB 1065, SHB 1065, HB 1212 |
|
Marijuana, processor's facilities, inspection by fire code official, alternatives, when:
HB 1920, SHB 1920 |
|
Marijuana, processors, contracts with processors, producers, or retailers:
ESHB 2472 |
|
Marijuana, processors, license fee, revising:
*
E2SHB 2334, CH 132 (2018) |
|
Marijuana, processors, retailer contracts with:
HB 2472, SB 6171 |
|
Marijuana, producer and processor premises, masking odors from:
HB 1911, SHB 1911 |
|
Marijuana, producer, processor, or researcher activities, odors from and visibility of:
HB 2744 |
|
Marijuana, producers and processors, license applicants, categories of:
HB 2770 |
|
Marijuana, producers and processors, testing of products of:
HB 2227, SHB 2227, 2SHB 2227 |
|
Marijuana, producers, contracts with processors, producers, or retailers:
ESHB 2472 |
|
Marijuana, producers, license fee, revising:
*
E2SHB 2334, CH 132 (2018) |
|
Marijuana, producers, sales for cannabis health and beauty aid production:
HB 2033, SB 5698 |
|
Marijuana, producers, sales to qualifying patients and providers:
HB 2021, SHB 2021, SB 5606, SB 5933 |
|
Marijuana, product testing laboratories, accreditation of:
SHB 2227, 2SHB 2227 |
|
Marijuana, production and processing standards for licensees:
HB 1461,
*
ESSB 5131, CH 317 (2017), SB 5323 |
|
Marijuana, production and products, excluding from "agricultural labor":
SHB 1692 |
|
Marijuana, production and products, excluding from overtime exemption:
SHB 1692 |
|
Marijuana, production and products, nuisance lawsuit protections:
HB 1692, SHB 1692 |
|
Marijuana, production or processing facilities, odors from, task force on:
HB 2845 |
|
Marijuana, regulatory revenues from, federal activities impeding, prohibitions:
HB 2124 |
|
Marijuana, retail licenses, delivery endorsement:
HB 1712, SHB 1712 |
|
Marijuana, retail licenses, forfeiture for failing to use by deadline:
HB 1126, SHB 1126,
*
ESSB 5131, CH 317 (2017) |
|
Marijuana, retail outlets in state and licenses held by licensees, number allowed:
HB 1096 |
|
Marijuana, retail outlets, local governments prohibiting within alcohol impact area:
SB 5282 |
|
Marijuana, retail outlets, local governments prohibiting, liquor revenue reduction:
HB 1099, SHB 1099 |
|
Marijuana, retail outlets, lockable drug box, donating:
*
HB 1250, CH 131 (2017) |
|
Marijuana, retail outlets, selling marijuana merchandise:
HB 1487, SHB 1487 |
|
Marijuana, retail outlets, siting or operation of, processes for prohibiting:
HB 2215, HB 2336, SHB 2336, HB 2484, SB 6291 |
|
Marijuana, retail product container, business or trade name and UBI requirements:
*
HB 2474, CH 43 (2018), SB 6170 |
|
Marijuana, retailers and co-owners, limiting aggregate licenses per business:
HB 1096, HB 1125,
*
ESSB 5131, CH 317 (2017) |
|
Marijuana, retailers, common ownership of, falsely indicating:
HB 2335, SHB 2335 |
|
Marijuana, retailers, contracts with processors, producers, or retailers:
ESHB 2472 |
|
Marijuana, retailers, license applicants, persons or entities considered to be:
HB 2770 |
|
Marijuana, retailers, license fee, revising:
*
E2SHB 2334, CH 132 (2018) |
|
Marijuana, retailers, private label sales by:
HB 2473, SB 6172 |
|
Marijuana, sales of, excluding from B&O tax exemption for agricultural products:
SHB 1692 |
|
Marijuana, sales of, tribal marijuana tax agreements:
SHB 1712 |
|
Marijuana, transfer of immature plants between producers and researchers:
*
ESSB 5131, CH 317 (2017), SB 5451 |
|
Marijuana, use or display in public, civil infraction:
HB 1416 |
|
Marijuana-infused edible food products, packaging and labeling of:
HB 1124 |
|
Marijuana-infused edible food products, sanitary processing, regulation of:
HB 1462,
*
SHB 1462, CH 138 (2017), SB 5324, SSB 5324 |
|
Methadone, as opioid replacement medication, availability:
HB 2489, SB 6150 |
|
Methadone, as opioid use disorder treatment medication, availability:
ESHB 2489, SSB 6150, 2SSB 6150 |
|
Methamphetamine, properties and transient accommodations contaminated by:
*
HB 1757, CH 115 (2017) |
|
Naloxone, as opioid overdose reversal medication, availability:
HB 2489, ESHB 2489, SB 6150, SSB 6150, 2SSB 6150 |
|
Naloxone, establishing access grant program and creating account:
HB 1505 |
|
Offenses, forfeiture of property, using proceeds for school funding:
HB 2136 |
|
Offenses, seizure and forfeiture of property, procedures and reporting:
HB 2718, SHB 2718, E2SHB 2718 |
|
Offenses, seizure and forfeiture of property, various provisions:
SB 5044, SB 5255, SSB 5255 |
|
Offenses, sentencing grid, changes to:
HB 2461, SB 5904 |
|
Offenses, sentencing grid, eliminating sunset provision:
SB 6517 |
|
Opiate drugs, prescribing, prescription monitoring program history review:
HB 2325, SB 6028 |
|
Opiate drugs, prescribing, risks and alternatives education for patients:
HB 2447 |
|
Opioid drugs, best practices for prescribing, practitioner continuing education:
ESHB 1339, ESHB 2489 |
|
Opioid drugs, prescribing, disciplinary boards and commissions to adopt rules:
*
ESHB 1427, CH 297 (2017), SSB 5248 |
|
Opioid drugs, prescribing, risks and alternatives education for patients:
ESHB 2489 |
|
Opioid drugs, prescription restrictions and practitioner requirements:
HB 1339, HB 2272, SB 6050 |
|
Opioid misuse and overdose prevention, drug czar for, governor to appoint:
SB 6391 |
|
Opioid overdose medications, K-12 and higher education access:
2SHB 2390 |
|
Opioid overdose medications, K-12 and higher education access and data:
HB 2390, SHB 2390, SB 6469 |
|
Opioid use disorder medications for treatment and overdose reversal:
ESHB 2489, SSB 6150, 2SSB 6150 |
|
Opioid use disorder medications for treatment, replacement, and overdose reversal:
HB 2489, SB 6150 |
|
Opioid use disorder treatment medications, treatment programs using:
HB 1427,
*
ESHB 1427, CH 297 (2017), HB 2489, ESHB 2489, SB 6150, SSB 6150, 2SSB 6150 |
|
Opioid-related overdoses, rapid response teams for:
HB 2489, ESHB 2489, SB 6150, SSB 6150, 2SSB 6150 |
|
Opioids, distributor morphine dose sales fee, revenues to fund naloxone access:
HB 1505 |
|
Over the counter, dispensed via prescription, retail sales tax exemption statement:
HB 1164 |
|
Prescription, cost and alternative purchasing methods disclosure by pharmacist:
HB 2623 |
|
Prescription, cost and utilization data, reporting:
HB 1541, SHB 1541, 2SHB 1541, SB 5401, SB 5586, SSB 5586, 2SSB 5586 |
|
Prescription, covered, point-of-sale maximum cost:
HB 2296, SHB 2296, SB 6026, SSB 6026 |
|
Prescription, covered, point-of-sale maximum cost and disclosures, studying:
SHB 2296 |
|
Prescription, donation program, donor form when drugs properly stored:
HB 1765,
*
SHB 1765, CH 205 (2017) |
|
Prescription, excessive price increases, studying:
SSB 5995 |
|
Prescription, for stage 4 metastatic cancer, prohibiting mandatory step therapy:
SB 5626 |
|
Prescription, generic drug price increase notification:
HB 2556, SB 5995 |
|
Prescription, insurance plans, coverage and cost continuity:
HB 1211, HB 2310, SB 5160, SB 6147, SSB 6147 |
|
Prescription, mail order services, unintentional use/enrollment, protections:
SB 5744, SSB 5744 |
|
Prescription, medicaid managed care drug list, new drugs and gene therapies:
HB 2565 |
|
Prescription, naturopath legend drug and controlled substance prescribing:
SB 5369 |
|
Prescription, new drugs/innovative therapies, drug utilization review board role:
ESHB 2565 |
|
Prescription, opioid drugs, disciplinary boards and commissions to adopt rules:
*
ESHB 1427, CH 297 (2017), SSB 5248 |
|
Prescription, opioid drugs, practitioner best practices continuing education:
ESHB 1339, ESHB 2489 |
|
Prescription, opioid drugs, restrictions and practitioner requirements:
HB 1339, HB 2272, SB 6050 |
|
Prescription, overdose reversal medications, standing order for prescribing:
HB 2489, ESHB 2489, SB 6150, SSB 6150, 2SSB 6150 |
|
Prescription, prescription monitoring program, confidentiality of information:
HB 2489, ESHB 2489, SB 6150, SSB 6150, 2SSB 6150 |
|
Prescription, prescription monitoring program, controlled substances history in:
HB 2325, SB 6028 |
|
Prescription, prescription monitoring program, electronic health records, work group:
2SSB 6150 |
|
Prescription, prescription monitoring program, electronic records systems vendors:
HB 2489, ESHB 2489, SB 6150, SSB 6150, 2SSB 6150 |
|
Prescription, prescription monitoring program, facilitating access to:
HB 2501 |
|
Prescription, prescription monitoring program, providing data from, when:
HB 1426, SHB 1426, E2SHB 1426,
*
ESHB 1427, CH 297 (2017), SB 5248, SSB 5248 |
|
Prescription, psychotropic medication, school requiring student be on, prohibiting:
HB 1788, SB 5448 |
|
Prescription, purchasing and pricing strategies, reporting:
SHB 1541, 2SHB 1541 |
|
Prescription, standardized drug benefit design, committee to develop, requirements:
SB 5697 |
|
Prescription, step therapy clinical review criteria and exception requests:
SB 6233 |
|
Prescription, step therapy in mental health treatment, restrictions:
SB 5782, SSB 5782 |
|
Prescription, step therapy override exception determinations, requirements:
SB 5757 |
|
Prescription, step therapy protocol usage literature review:
SSB 6233 |
|
Prescription, take-back program for unwanted medications:
HB 1047,
*
ESHB 1047, CH 196 (2018) |
|
Prescription, warehousing and reselling, preferential B&O tax rate, repealing:
HB 2186, SHB 2186, SB 5839, SB 5929 |
|
Prescriptions, electronic communication of information:
HB 2689 |
|
Substance use disorder, involuntary commitment court hearings by video:
SB 6124,
*
SSB 6124, CH 305 (2018) |
|
Suicide awareness, suicide-safer homes project, task force, and account, creating:
HB 1612, SHB 1612,
*
E2SHB 1612, CH 262 (2017) PV |
|